Novo Nordisk to present early-stage trial data for new obesity drug at investor meeting

Novo Nordisk, maker of weight loss drug Wegovy, on Thursday said it would present early-stage trial data for its highly anticipated pipeline drug, Amycretin, which is also for the treatment of obesity.